These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide and underscore the importance of laboratory medicine in our collective response to this unprecedented health crisis. Additional items for considerations, as more evidence becomes available, include antigen testing, test harmonization, point-of-care assays, and quantitative PCR and serological testing. The IFCC Taskforce will continue to evaluate the emerging evidence on these other testing paradigms and will develop further recommendations in the near future.
Editorial and executive summary: IFCC Interim Guidelines on clinical laboratory testing during the COVID-19 pandemic
Lippi, Giuseppe;
2020-01-01
Abstract
These evidence-based recommendations will provide practical guidance to clinical laboratories worldwide and underscore the importance of laboratory medicine in our collective response to this unprecedented health crisis. Additional items for considerations, as more evidence becomes available, include antigen testing, test harmonization, point-of-care assays, and quantitative PCR and serological testing. The IFCC Taskforce will continue to evaluate the emerging evidence on these other testing paradigms and will develop further recommendations in the near future.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
